Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

ASCEND is funded by the British Heart Foundation with additional support from Bayer Healthcare and AG Mylan (previously Abbott Laboratories) who provide the study treatments and some funding to cover the drug packaging. Alzheimer’s Research UK have provided a grant to allow the measurement of cognitive function in ASCEND. ASCEND is co-ordinated by CTSU which It is funded by the Medical Research Council as well as by grants from the British Heart Foundation and from Cancer Research UK.


British Heart Foundation